JP6629782B2 - 加齢黄斑変性症のリスク評価方法及びシステム - Google Patents

加齢黄斑変性症のリスク評価方法及びシステム Download PDF

Info

Publication number
JP6629782B2
JP6629782B2 JP2017074848A JP2017074848A JP6629782B2 JP 6629782 B2 JP6629782 B2 JP 6629782B2 JP 2017074848 A JP2017074848 A JP 2017074848A JP 2017074848 A JP2017074848 A JP 2017074848A JP 6629782 B2 JP6629782 B2 JP 6629782B2
Authority
JP
Japan
Prior art keywords
evaluation
group
element group
elements
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017074848A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018179565A (ja
JP2018179565A5 (cg-RX-API-DMAC7.html
Inventor
稲垣　精一
精一 稲垣
直幸 岡本
直幸 岡本
武範 猪俣
武範 猪俣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RENATECH CO., LTD.
Juntendo University
Original Assignee
RENATECH CO., LTD.
Juntendo University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RENATECH CO., LTD., Juntendo University filed Critical RENATECH CO., LTD.
Priority to JP2017074848A priority Critical patent/JP6629782B2/ja
Priority to PCT/JP2018/014382 priority patent/WO2018186434A1/ja
Priority to US16/500,530 priority patent/US20210116466A1/en
Publication of JP2018179565A publication Critical patent/JP2018179565A/ja
Publication of JP2018179565A5 publication Critical patent/JP2018179565A5/ja
Application granted granted Critical
Publication of JP6629782B2 publication Critical patent/JP6629782B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/164—Retinal disorders, e.g. retinopathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
JP2017074848A 2017-04-04 2017-04-04 加齢黄斑変性症のリスク評価方法及びシステム Active JP6629782B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2017074848A JP6629782B2 (ja) 2017-04-04 2017-04-04 加齢黄斑変性症のリスク評価方法及びシステム
PCT/JP2018/014382 WO2018186434A1 (ja) 2017-04-04 2018-04-04 加齢黄斑変性症のリスク評価方法及びシステム
US16/500,530 US20210116466A1 (en) 2017-04-04 2018-04-04 Method and system for evaluating risk of age-related macular degeneration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017074848A JP6629782B2 (ja) 2017-04-04 2017-04-04 加齢黄斑変性症のリスク評価方法及びシステム

Publications (3)

Publication Number Publication Date
JP2018179565A JP2018179565A (ja) 2018-11-15
JP2018179565A5 JP2018179565A5 (cg-RX-API-DMAC7.html) 2019-08-29
JP6629782B2 true JP6629782B2 (ja) 2020-01-15

Family

ID=63713171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017074848A Active JP6629782B2 (ja) 2017-04-04 2017-04-04 加齢黄斑変性症のリスク評価方法及びシステム

Country Status (3)

Country Link
US (1) US20210116466A1 (cg-RX-API-DMAC7.html)
JP (1) JP6629782B2 (cg-RX-API-DMAC7.html)
WO (1) WO2018186434A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7157941B2 (ja) * 2020-08-05 2022-10-21 憲一 佐藤 癌罹患判定方法、装置、およびプログラム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010074940A1 (en) * 2008-12-23 2010-07-01 Alcon Research, Ltd. Compositions and nutritional supplements for improving ocular health and reducing ocular inflammatory response
JPWO2014168154A1 (ja) * 2013-04-08 2017-02-16 三菱レイヨン株式会社 眼疾患を評価するためのマイクロアレイ及び眼疾患の評価方法
KR102305151B1 (ko) * 2014-09-15 2021-09-27 가부시키가이샤 레나텟쿠 암 평가 방법 및 암 평가 시스템
JP6459495B2 (ja) * 2014-12-24 2019-01-30 理研ビタミン株式会社 ワカメの生育海域を判別する方法

Also Published As

Publication number Publication date
WO2018186434A1 (ja) 2018-10-11
JP2018179565A (ja) 2018-11-15
US20210116466A1 (en) 2021-04-22

Similar Documents

Publication Publication Date Title
Rahman et al. Early pregnancy exposure to metal mixture and birth outcomes–A prospective study in Project Viva
KR102635700B1 (ko) 암 리스크 평가 방법 및 암 리스크 평가 시스템
KR102305151B1 (ko) 암 평가 방법 및 암 평가 시스템
Howe et al. Prenatal metal mixtures and fetal size in mid-pregnancy in the MADRES study
Ashrap et al. Performance of urine, blood, and integrated metal biomarkers in relation to birth outcomes in a mixture setting
Palomares et al. Olfactory dysfunctions and chronic kidney disease: A scoping review
JP6629782B2 (ja) 加齢黄斑変性症のリスク評価方法及びシステム
CN109841278A (zh) 一种以心血管标志及机械学习运算法进行冠心症筛检的方法
WO2011161544A2 (ja) 疲労のバイオマーカーおよびその利用
Kubala-Kukuś et al. Statistical analysis of analytical results near detection limits with illustrations using elemental determinations in medical and biological samples by total reflection X-ray fluorescence
JP7698805B2 (ja) 認知症リスク評価方法及び認知症リスク評価システム
US7056745B2 (en) Diagnostic method and apparatus
Levinson Clinical validation of biomarkers for predicting risk
US12112834B2 (en) System and method for non-invasive quantification of blood biomarkers
Gowda Molecular Diagnosis of Glial Cell Brain Cancers Using Handheld Mass Spectrometry Device
Bhaskar et al. CNN-CatBoost ensemble deep learning model for enhanced disease detection and classification of kidney disease
JP6875451B2 (ja) 犬のがんリスク評価方法及びがんリスク評価システム
WO2024052898A1 (en) System and method for non-invasive quantification of blood biomarkers
WO2025008466A1 (en) Use of a biomarker for determining the risk of an individual to have hepatic encephalopathy
RU2307351C2 (ru) Способ исследования сыворотки крови
Saldaña Improving Lead Exposure Assessment Using Dried Blood Spots
JP2021131345A (ja) 癌の判別方法、判別装置およびプログラム
Harvey et al. Holistic Performance Institute Position Stand: Hair Testing
CN120299701A (zh) 2型糖尿病合并轻度认知功能障碍的风险预测方法和系统
WO2020067261A1 (ja) 犬のがんリスク評価方法及びがんリスク評価システム

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190719

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190719

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20190719

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20190806

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190809

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191008

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20191113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191205

R150 Certificate of patent or registration of utility model

Ref document number: 6629782

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250